文献速递血管炎

抗中性粒细胞胞质抗体相关性血管炎疾病活动度与器官损伤的非侵入性生物标志物:一项系统综述

Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review.
PubMed 文献 · RMD Open · 2024-02-09

该系统综述检索2012年至今的科学数据库,纳入22项高质量研究,描述性汇总血液与尿液非侵入性生物标志物在评估抗中性粒细胞胞质抗体(ANCA)相关性血管炎(AAV)疾病活动度和器官损伤中的价值;作者认为将单个标志物纳入组合型生物标志物谱可能有助于增强临床决策。

要点

  • 纳入22项高质量研究,覆盖抗中性粒细胞胞质抗体、免疫细胞、补体因子、基因表达谱、细胞因子、趋化因子等血液与尿液标志物。
  • 许多标志物涉及替代补体途径、中性粒细胞活化和巨噬细胞活化。
  • 作者认为将单个标志物纳入组合型生物标志物谱可能增强临床决策,并指出嗜酸性肉芽肿性多血管炎与儿童起病AAV研究较少。

核心结论

  • 这是首个当代系统综述,汇总AAV相关疾病活动度和器官损伤的非侵入性生物标志物的价值。
  • 作者认为将单个标志物纳入组合型生物标志物谱可能增强临床决策。
  • 作者指出存在许多未满足的需求,并认为需在大规模前瞻性研究中对候选标志物做进一步验证。

研究设计与样本

  • 研究为系统综述,检索科学数据库自2012年至今,以识别符合纳入标准的研究。
  • 采用加强观察性流行病学研究报告(STROBE)清单评估队列、病例对照和横断面研究的质量,采用非随机研究偏倚风险评估工具或Cochrane偏倚风险工具2.0评估随机对照试验。
  • 共纳入22项高质量研究,对AAV相关疾病活动度和器官损伤的非侵入性(血液或尿液)生物标志物数据做描述性汇总。

主要发现

  • 纳入研究报道了血液和尿液生物标志物在评估AAV患者疾病活动度和/或器官损伤中的价值,包括抗中性粒细胞胞质抗体、免疫细胞、补体因子、基因表达谱、细胞因子、趋化因子和其他蛋白质。
  • 许多生物标志物涉及替代补体途径、中性粒细胞活化和巨噬细胞活化。
  • 作者指出,很少有研究涉及嗜酸性肉芽肿性多血管炎和儿童起病AAV患者。

临床怎么用

  • 作者认为将单个标志物纳入组合型生物标志物谱可能增强临床决策。
  • 作者指出,需在大规模前瞻性研究中对候选标志物做进一步验证,以弥合现有知识缺口并将精准健康应用于系统性血管炎。

局限性

  • 原文指出,很少有研究涉及嗜酸性肉芽肿性多血管炎和儿童起病AAV患者。
  • 原文结论指出,需在大规模前瞻性研究中对候选标志物做进一步验证,以弥合现有知识缺口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), histopathological assessment of affected tissue is often necessary for diagnosis and assessment of disease extent. There is a requirement for validated non-invasive biomarkers to avoid the need for serial tissue biopsies. METHODS: A systematic review of scientific databases from 2012 until present was performed to identify studies fulfilling the inclusion criteria. Studies were assessed for quality using the Strengthening the Reporting of Observational Studies in Epidemiology checklist for cohort, case-control and cross-sectional studies and the Risk of Bias Assessment tool for Non-randomised Studies, or the Cochrane Risk of Bias tool 2.0 for randomised controlled trials. A descriptive synthesis of the data for non-invasive (blood-based or urinary) biomarkers of AAV-related disease activity and organ damage was performed. RESULTS: Twenty-two high quality studies were included. These articles reported the value of blood-based and urinary biomarkers including anti-neutrophil cytoplasmic antibodies, immune cells, complement factors, gene expression profiles, cytokines, chemokines and other proteins in the assessment of disease activity and/or organ damage in patients with AAV. Many of these biomarkers involve the alternative complement pathway, neutrophil activation and macrophage activation. CONCLUSION: This is the first contemporary systematic review synthesising the value of non-invasive biomarkers of AAV-related disease activity and organ damage. The incorporation of individual markers in combined biomarker profiles might enhance clinical decision-making. Many unmet needs were identified; few studies involve oeosinophilic granulomatosis with polyangiitis and patients with childhood-onset AAV. Further validation of the candidate biomarkers is warranted in large prospective studies to bridge the existing knowledge gaps and apply precision health to systemic vasculitis.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Renson T, Kelly MM, Benediktsson H, et al. Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review. RMD Open. 2024. PMID: 38341193. doi:10.1136/rmdopen-2023-003579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。